Analysis of Differential Proteins and Maternal Influencing Factors of Septic Shock in Neonates
NCT ID: NCT06206590
Last Updated: 2024-01-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
116 participants
OBSERVATIONAL
2023-11-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
NeoAMR Observational Study in Neonatal Sepsis
NCT03721302
Simplified Antibiotic Therapy for Sepsis in Young Infants
NCT01027429
Lung Ultrasound-guided Fluid Resuscitation in Neonatal Septic Shock
NCT06144463
Performance of Interleukin-27 Cord Blood Level as A Biomarker Predicating Early Onset Neonatal Sepsis
NCT05589909
Continuos Terlipressin Infusion in Septic Shock
NCT01697410
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
exposed group
Contains differential proteins
Whole-proteomic assay
Whole-proteomic analysis was performed on all the blood samples
non-exposed group
No differential protein
Whole-proteomic assay
Whole-proteomic analysis was performed on all the blood samples
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Whole-proteomic assay
Whole-proteomic analysis was performed on all the blood samples
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Day
1 Day
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Guangdong Women and Children Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ma Dongju
Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
xiuzhen ye
Role: STUDY_CHAIR
Guangdong Women and Children Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Guangdong Women and Children Hospital
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202301393
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.